Literature DB >> 12656449

Managing chronic renal insufficiency--intertwined roles of non-nephrologist and nephrologist.

Onyekachi Ifudu1, Eli A Friedman.   

Abstract

This article reviews reported evidence on the clinical aspects of chronic renal insufficiency, proffers the relative roles of nephrologist and nonnephroloist in the management of chronic renal insufficiency and highlights common errors in the management of patients with chronic renal insufficiency. A paradigm is proposed for management of individuals with progressive chronic renal insufficiency according to evidence of efficacy of options in intervention. Recognizing the interdependence of generalist/family physician and nephrologist, key issues surrounding the timing of referral for specialized renal care are examined. By preparing the patient for future uremia therapy well in advance of need, the stress of coping with a life-threatening crisis can be muted and selection of a specific modality (peritoneal dialysis, hemodialysis, renal transplantation) can be made with full thought, family support, and the time to effect the regimen. Common errors in handling patients with deteriorating renal function are examined with advice for their avoidance.

Entities:  

Mesh:

Year:  2003        PMID: 12656449      PMCID: PMC2594371     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  52 in total

1.  Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group.

Authors:  I Giatras; J Lau; A S Levey
Journal:  Ann Intern Med       Date:  1997-09-01       Impact factor: 25.391

2.  Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients.

Authors:  S Kuriyama; H Tomonari; H Yoshida; T Hashimoto; Y Kawaguchi; O Sakai
Journal:  Nephron       Date:  1997       Impact factor: 2.847

3.  Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.

Authors:  M Ravid; D Brosh; D Ravid-Safran; Z Levy; R Rachmani
Journal:  Arch Intern Med       Date:  1998-05-11

Review 4.  Current strategies for management of hypertensive renal disease.

Authors:  M A Moore; M Epstein; L Agodoa; L D Dworkin
Journal:  Arch Intern Med       Date:  1999-01-11

Review 5.  Anemia during the predialysis period: A key to cardiac damage in renal failure.

Authors:  D Silverberg; M Blum; G Peer; A Iaina
Journal:  Nephron       Date:  1998-09       Impact factor: 2.847

6.  Timing of initiation of uremia therapy: where is the science?

Authors:  O Ifudu
Journal:  Int J Artif Organs       Date:  1997-11       Impact factor: 1.595

7.  Role of dyslipidemia in the progression of chronic renal disease.

Authors:  P Cappelli; L Di Liberato; A Albertazzi
Journal:  Ren Fail       Date:  1998-03       Impact factor: 2.606

8.  The relationship between hemoglobin levels and diabetic retinopathy.

Authors:  Q Qiao; S Keinänen-Kiukaanniemi; E Läärä
Journal:  J Clin Epidemiol       Date:  1997-02       Impact factor: 6.437

Review 9.  Implications of the diabetes control and complications trial for renal outcomes and medical nutrition therapy.

Authors:  L M Delahanty
Journal:  J Ren Nutr       Date:  1998-04       Impact factor: 3.655

10.  Zidovudine is beneficial in human immunodeficiency virus associated nephropathy.

Authors:  O Ifudu; T K Rao; C C Tan; H Fleischman; K Chirgwin; E A Friedman
Journal:  Am J Nephrol       Date:  1995       Impact factor: 3.754

View more
  1 in total

1.  Barriers to successful care for chronic kidney disease.

Authors:  Oliver Lenz; Durga P Mekala; Daniel V Patel; Alessia Fornoni; David Metz; David Roth
Journal:  BMC Nephrol       Date:  2005-10-27       Impact factor: 2.388

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.